Medpace Holdings Inc vs Quantum Computing Inc — how do they compare? Medpace Holdings Inc trades at $528.29 (market cap $15.08B), while Quantum Computing Inc trades at $8.11 (market cap $1.79B). The key difference: Medpace Holdings Inc is far larger — about 8.4× Quantum Computing Inc's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Quantum Computing Inc nearer its low. Which is the better fit depends on your goals.
| MEDP | QUBT | |
|---|---|---|
Market Cap | $15.08B | $1.79B |
Sector | Technology | Technology |
52-Week High | $620.59 | $24.62 |
52-Week Low | $308.88 | $6.31 |
Enterprise Value | $14.55B | $803.83M |
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
Quantum Computing Inc. (QUBT) trades at $7.92, up 1.54% today, while technical indicators signal a bearish trend. The company shows minimal revenue of $682,000 for 2025 with a net loss of $18.67 million, resulting in negative profit margins. Analysts maintain a bullish consensus with a $26 price target, citing potential from commercial backlog and policy support, despite ongoing cash burn and a recent legal investigation into corporate governance.
QUBT offers high-risk, high-reward potential driven by quantum computing commercialization prospects, but faces significant execution risks and financial instability. The stock's outlook hinges on revenue scaling and managing cash flow, with substantial downside if growth targets are missed.
Trailing returns across standard periods
Latest headlines on both assets
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →Quantum Computing Inc. is a company focused on providing accessible quantum computing and quantum-enhanced software solutions for complex problems. The company's technology is designed to run on both classical and quantum hardware, enabling businesses to explore the power of quantum computing today for applications in finance, drug discovery, and logistics. QUBT offers a platform that makes quantum algorithms and software available through the cloud, aiming to democratize access to this advanced computing paradigm.
Read more on QUBT →